Posts by Jenna Dehn

What’s New in PET/CT Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer. PET/CT Updates, Research & Education January 2019 Purpose The aim of this study was to investigate the value of five typical fluorine-18-fluorodeoxyglucose PET/computed tomography (CT) parameters (including SUVmax, SUVmean, SUVpeak, MTV and TLG) in…

What’s New in PET/CT Total FDG lesion number on PET/CT predicts survival of esophageal carcinoma patients with recurrence following curative surgery. PET/CT Updates, Research & Education December 2018 Purpose Total lesion number is a prognostic determinant in recurrent esophageal cancer, but this requires multiple tests. Here, we investigated the prognostic value of total FDG lesion…

What’s New in PET/CT Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer. PET/CT Updates, Research & Education November 2018 Purpose The standard treatment for patients with stage III non-small cell lung cancer (NSCLC), unsuitable for resection and with good performance, is definitive…

What’s New in PET/CT 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men. PET/CT Updates, Research & Education October 2018 Purpose 18F-FDG PET/CT has demonstrated substantial value in systemic staging of newly diagnosed breast cancer in women. However, it is not known whether breast cancer in male patients benefit similarly. This study…